DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
This Quarter Return
+1.58%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$251M
AUM Growth
+$251M
(-11%)
Cap. Flow
-$31.8M
Cap. Flow
% of AUM
-12.68%
Top 10 Holdings %
Top 10 Hldgs %
68.46%
Holding
113
New
7
Increased
18
Reduced
9
Closed
14
Top Buys
| 1 |
DocGo
DCGO
|
$3.54M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$1.94M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$1.27M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$788K |
| 5 |
MREO
Mereo BioPharma
MREO
|
$742K |
Top Sells
| 1 |
FTAI Aviation
FTAI
|
$16.8M |
| 2 |
Westrock Coffee
WEST
|
$4.89M |
| 3 |
Panagram BBB-B CLO ETF
CLOZ
|
$4.75M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
$3.65M |
| 5 |
Ligand Pharmaceuticals
LGND
|
$2.53M |
Sector Composition
| 1 | Healthcare | 30.83% |
| 2 | Materials | 28.51% |
| 3 | Financials | 14.07% |
| 4 | Communication Services | 8.23% |
| 5 | Technology | 1.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Calumet Specialty Products
CLMT
$1.41B
| $69.4M | 27.7% |
4,325,000
| – | – |
|
2
Apollo Global Management
APO
$77.9B
| $26.6M | 10.6% |
225,000
| – | – |
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $20.6M | 8.21% |
112,220
| – | – |
|
|
4
Panagram BBB-B CLO ETF
CLOZ
$846M
| $14.6M | 5.84% |
542,868
-176,500
| -25% | -$4.75M |
|
|
5
DocGo
DCGO
$153M
| $9.49M | 3.79% |
3,070,850
+1,145,850
| +60% | +$3.54M |
|
|
6
Ligand Pharmaceuticals
LGND
$3.15B
| $7.16M | 2.86% |
85,000
-30,000
| -26% | -$2.53M |
|
7
Pfizer
PFE
$141B
| $6.96M | 2.78% |
248,737
+1,200
| +0.5% | +$33.6K |
|
8
Invesco AAA CLO Floating Rate Note ETF
ICLO
$344M
| $6.11M | 2.44% |
237,753
-69,266
| -23% | -$1.78M |
|
9
Ardelyx
ARDX
$1.53B
| $5.73M | 2.29% |
772,867
-52,133
| -6% | -$386K |
|
|
AVDL
10
Avadel Pharmaceuticals
AVDL
$1.43B
| $4.68M | 1.87% |
333,000
| – | – |
|
11
JPMorgan Chase
JPM
$829B
| $4.24M | 1.69% |
20,985
| – | – |
|
12
OmniAb
OABI
$230M
| $4.19M | 1.67% |
1,118,505
+15,000
| +1% | +$56.2K |
|
13
Viking Therapeutics
VKTX
$3.04B
| $4.03M | 1.61% |
76,036
-25,400
| -25% | -$1.35M |
|
14
Catalyst Pharmaceutical
CPRX
$2.52B
| $3.28M | 1.31% |
212,000
+24,148
| +13% | +$374K |
|
|
VRNA
15
Verona Pharma
VRNA
$9.16B
| $2.94M | 1.17% |
203,000
+88,000
| +77% | +$1.27M |
|
|
16
Janus Henderson AAA CLO ETF
JAAA
$24.9B
| $2.72M | 1.08% |
53,397
-71,682
| -57% | -$3.65M |
|
17
Digimarc
DMRC
$188M
| $2.59M | 1.03% |
83,557
| – | – |
|
|
INZY
18
DELISTED
Inozyme Pharma
INZY
| $2.52M | 1% |
564,549
| – | – |
|
19
GSK
GSK
$79.9B
| $2.5M | 1% |
65,000
| – | – |
|
20
Immunovant
IMVT
$2.56B
| $2.42M | 0.96% |
91,500
+6,200
| +7% | +$164K |
|
21
Ironwood Pharmaceuticals
IRWD
$214M
| $2.41M | 0.96% |
370,000
+94,000
| +34% | +$613K |
|
22
CSX Corp
CSX
$60.6B
| $2.34M | 0.93% |
70,000
| – | – |
|
|
ESGR
23
DELISTED
Enstar Group
ESGR
| $2.29M | 0.91% |
7,500
| – | – |
|
24
Travere Therapeutics
TVTX
$1.56B
| $2.19M | 0.87% |
265,966
+35,000
| +15% | +$288K |
|
|
25
Syndax Pharmaceuticals
SNDX
$1.41B
| $2.13M | 0.85% |
103,826
+38,351
| +59% | +$788K |
|